ESGO 2015 Congress: Clinical Trials Session

Clinical trials play a key role in improving the prevention, diagnosis and treatment of gynaecological cancers, as well as setting standards of care and evaluating more effective therapy options for women diagnosed with a gynecologic cancer.

Watch the advances and open questions of the primary clinical trials in the EU, as presented and discussed at the Clinical Trials since ESGO 2013 session during ESGO 2015 congress in Nice, France, including:

  •  A comprehensive review of all ongoing and future clinical trials in ovarian, endometrial, cervical, vulvar cancers and rare tumors.
  • Highlights of the unresolved problems in these fields.

Advance your practice by exploring the selected webcasts below on clinical and surgical trails in the EU.

 

Clinical Trials in Endometrial Cancer: List of Ongoing and Future Clinical Trials in EU and Unanswered Questions
Mirza M. 

 
 
 
 
 
Clinical Trials for Cervix Cancer: List of Ongoing and Future Clinical Trials in EU and Unanswered Questions
Kenter G. 
 
 
Clinical Trial for Ovarian Carcinoma: List of Ongoing and Future Clinical Trials in EU and Unanswered Questions
Vergote I. 
 
 
Clinical Trial for Rare Tumours: List of Ongoing and Future Clinical Trials in EU and Unanswered Questions
Ray-Coquard I. 

Up Coming ENGOT Meeting

Frankfurt, Germany, October 12-13, 2017

Don't miss out on the latest updates

Save the Date!

You May Also Like

GCA WORKSHOPS

Watch the Webcasts 

 

Read More

CLINICAL TRIALS

Latest Published Research

 

Read More

FOR PATIENTS

Key Insights

 

Read More

ESGO 2017 Congress

Clinical Trials Session

 

Read More